Category: Resuscitation
Zoll Medical wins 510(k) clearance for its AED Plus CPR-assist technology.
Asahi Kasei (TYO:3407) subsidiary Zoll Medical won 510(k) clearance from the FDA for its fully-automated AED Plus device, which improves on the former semi-automatic model.
The new automated external defibrillator allows emergency responders to pre-program a shock instead of pushing the "shock" button.
Healthcare giant GE recalls a resuscitation upgrade kit installed in certain infant warmers over concerns that mix-ups in labeling could lead to significant harm.
The FDA gave Class I status to GE Healthcare's (NYSE:GE) recall of upgrade kits for some infant warmers over concerns that mislabeling in the kits may result in neonatal patients getting the wrong oxygen concentrations.
Zoll CEO Rick Packer tells MassDevice.com about making the decision to sign the pledge to share data in the interest of patient safety.
Medical device maker Zoll Medical is among the 1st medical device companies to sign on to the patient safety and medical device data pledge proposed by Masimo (NSDQ:MASI) founder & CEO Joe Kiani this weekend.
The pledge includes promises to open up patient data gathered by medical devices to clinicians, patients and anyone else who can help improve patient care.
Asahi Medical completes the first stage of its $2.3 billion acquisition of Zoll Medical, paying $93 apiece for 93.8% of Zoll's outstanding shares and launching a 3-day offering period for the rest.
Chelmsford, Mass.-based resuscitation device maker Zoll Medical (NSDQ:ZOLL) sealed the deal with Japan's Asahi Kasei Corp. (TYO:3407) over the weekend.
ZOLL shares spike 24% on news of a $2.2 billion buyout by Japan's Asahi Kasei Corp., which promises to keep the current management team, business units and operations intact.
Zoll Medical (NSDQ:ZOLL) is winning a lot of Wall Street love this morning on the news of a $2.21 billion cash offer from Asahi Kasei Corp. (TYO:3407).
ZOLL shares jumped 23.5% to $92.74 in morning trading today, after the Chelmsford, Mass.-based resuscitation device maker said it reached an agreement to merge with Asahi.
Zoll's stock jumped by nearly a quarter overnight after the release of its 2011 earnings report revealing record sales and profits for 2011; plus, Bovie Medical's Q3 profits soar despite sales slide; Cardium Therapeutics pares Q3 losses; Daxor Corp. swings to Q3 loss; Derma Sciences grows Q3 sales, losses; Edap swings to Q3 profits; Fonar Corp.'s Q1 sales, earnings rise; sales plunge as Imris swings to Q3 red; InspireMD's Q3 sales, losses increase; Oridion's Q3 sales, earnings rise; sales down as Patient Safety Technologies swings to Q3 loss; PLC Systems boosts Q3 sales, losses soar; Sanuwave cuts Q3 losses despite lower sales; and Tengion's Q3 losses mount.
Zoll reported record numbers in its top and bottom line for fiscal year 2011, sending its stock up 23 percent overnight.
Zoll shares were trading at $44.35 in the early afternoon today, up from last night's $35.98 close.
The company's 2011 sales hit a record high of $523.7 million, 18 percent higher than the $444 million posted last year.
Medtronic finally finds a buyer for its low-margin Physio-Control subsidiary, agreeing to sell it to Bain Capital for about $487 million.
Less than a month after new CEO Omar Ishrak signaled Medtronic's (NYSE:MDT) continued interest in selling its troublesome Physio-Control resuscitation business, the company found a buy ready to put nearly half a billion dollars on the table: private equity firm Bain Capital.
